Inozyme recently featured new clinical insights and hosted an educational symposium at the Joint Congress of the European ...

Natural Chromium Picolinate- this ingredient helps you control hunger and food cravings. Additionally, it makes your system ...

Menopausal support (energy, mood, muscle retention): creatine is a woman’s powerful ally during the menopause face as it ...

Multiple long-term LM survivors in those patients receiving multiple doses of REYOBIQ. RNA sequencing data show early tumor apoptosis and activation of innate immune responses. Up ...

H.C. Wainwright 6th Annual Neuro Perspectives Conference When: Tuesday, June 17 th, 2025 at 7:00 pm ET. A webcast is available to clients of the firm at https://hcwevents.com/.

The sessions will be webcast and can be accessed by visiting the Events section of the Altimmune website.

On April 23, 2025, the Company announced that three abstracts on Versamune® HPV (PDS0101) were selected for presentation at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting, to be ...

The first active clinical trial site is the Royal North Shore Hospital in Sydney, Australia, which is expected to begin patient enrollment in Q2 2025. Additional clinical trial sites in Australia, ...

QRX003 is being well tolerated by the patient and no adverse events have been reported. As a result of these positive initial results, the patient is expected to continue to be treated with QRX003 ...

A live webcast and replay of the fireside chats will be available on the Events & Presentations page in the Investor Relations section of Pyxis Oncology’s website, ir.pyxisoncology.com.

MONTREAL and CHARLOTTE, N.C., May 14, 2025 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today reported financial results for the first quarter ended March 31, 2025. The Company ...

Lurie Children's Hospital of Chicago, a top-ranked hospital, is ready to evaluate patients for ZEVASKYN treatment - - Abeona Assist™ comprehensive patient services program in place to offer ...